DXA Screening for Seniors: Not for Everyone
No, DXA bone density scans should not be ordered for all senior patients as routine screening—screening is recommended for all women ≥65 years, but for men the evidence is insufficient and routine screening is not currently recommended. 1
Sex-Specific Recommendations
Women ≥65 Years: Screen Routinely
The 2025 USPSTF guideline provides a Grade B recommendation for screening all women aged 65 years and older with DXA bone mineral density testing 1. This recommendation is based on evidence showing that:
- DXA accurately predicts fracture risk (AUCs 0.64-0.86 for hip fractures) 1
- Treatment following positive screening reduces fracture incidence
- The benefits clearly outweigh harms in this population
For postmenopausal women <65 years, screen only if they have increased fracture risk based on a formal clinical risk assessment tool (such as FRAX) 1. The USPSTF suggests a 2-step approach: first use a risk assessment tool, then order DXA if risk is elevated 1.
Men: Insufficient Evidence
The USPSTF concludes there is insufficient evidence (Grade I statement) to recommend for or against routine osteoporosis screening in men 1. While some organizations recommend screening men ≥70 years, and the American Academy of Family Physicians specifically recommends against screening men <70 years without risk factors, the highest quality current evidence (2025 USPSTF) does not support universal screening 1.
The evidence gap exists because:
- Limited data on screening accuracy in men
- Fewer studies on treatment benefits in men
- Uncertainty about optimal screening thresholds 1
Key Clinical Considerations
What "Senior" Actually Means
The term "senior" is imprecise. The evidence-based age cutoffs are:
- Women: 65 years is the threshold for routine screening
- Men: No established screening age due to insufficient evidence
- Don't use chronological age alone—consider fracture risk factors
Risk Factors That Lower Screening Threshold
For women <65 years (and potentially for men if screening is considered), assess these risk factors 2, 3:
- Prior fragility fracture
- Glucocorticoid use (≥3 months at ≥5 mg/day prednisone equivalent)
- Parental history of hip fracture
- Current smoking
- Excessive alcohol consumption
- Low body weight (<127 lbs or BMI <21)
- Rheumatoid arthritis
- Secondary causes of osteoporosis
Common Pitfalls to Avoid
Don't assume all "seniors" need screening. The evidence supports sex-specific approaches, not age-based blanket screening 1.
Don't screen men routinely without considering the evidence gap. While osteoporosis in men is underdiagnosed, the USPSTF explicitly states insufficient evidence exists to recommend screening 1. Clinical judgment and shared decision-making are essential if considering screening in men.
Don't order DXA without a plan for acting on results. Screening is only indicated when you would treat based on findings 3. If a patient has contraindications to all osteoporosis therapies or would decline treatment, screening provides no benefit.
Don't forget that DXA is currently underutilized even in populations where it's clearly indicated 4. Focus screening efforts on women ≥65 years who haven't been tested rather than expanding to populations without evidence support.
Screening Intervals
Evidence on optimal rescreening intervals is limited 1. The USPSTF notes this as a research gap but suggests intervals should be individualized based on initial results and risk factors. Generally, if initial screening is normal, rescreening every 2-5 years is reasonable for women ≥65 years, though this is not firmly established 1.
The Bottom Line for Practice
Screen all women ≥65 years with DXA at the hip and lumbar spine 1. For men, even those ≥70 years, routine screening lacks sufficient evidence support and should be based on individual risk assessment and shared decision-making rather than applied universally 1. The answer to "all seniors" is definitively no—sex and specific risk factors matter more than age alone.